TAN-1057 A | Solubility of Things

Identification

Molecular formula

C₂₀H₂₀N₄O₄

CAS number

143965-94-0

IUPAC name

3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide

State

The compound is typically a solid at room temperature, known for its stability and resistance to melting under normal conditions.

Melting point (Celsius)

239.00

Melting point (Kelvin)

512.15

Boiling point (Celsius)

481.00

Boiling point (Kelvin)

754.15

General information

Molecular weight

392.40g/mol

Molar mass

392.4040g/mol

Density

1.6200g/cm³

Appearence

The compound exhibits a yellow, crystalline solid appearance. It has a pronounced crystalline structure when observed under the microscope.

Comment on solubility

Solubility of 3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide

The solubility of a compound can significantly influence its applications and effectiveness in various fields, including pharmaceuticals and materials science. For the compound 3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide, understanding its solubility characteristics is essential for its practical use.

This compound is expected to exhibit varying solubility depending on the solvent. Here are some key points to consider:

Polar Solvents: Given its multiple hydroxyl groups, the compound may have increased solubility in polar solvents such as water and alcohols.
Non-Polar Solvents: Conversely, its solubility in non-polar solvents may be significantly lower due to the presence of polar functional groups.
pH Dependence: The solubility may also vary with pH, as ionization of the hydroxyl groups could influence its overall solubility profile.
Temperature Effects: Increased temperatures typically improve solubility for many compounds, allowing for better dissolution in solvents.

In conclusion, while specific solubility data for this compound may not be readily available, its structural characteristics suggest that it could demonstrate a strong solubility profile in polar environments, making it a compound of interest for further solubility studies.

Interesting facts

Interesting Facts about 3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide

This compound is a fascinating example of a complex organic molecule with intriguing pharmacological properties. Here are some engaging facts to help illuminate its significance:

Unique Structure: The compound features a benzodiazepine core, known for its longstanding use in medicine, notably for their anxiolytic and sedative effects. The incorporation of a tetrahydropyrrolo moiety adds a unique structural twist that can influence binding interactions with biological targets.
Hydroxyl Groups: The presence of hydroxyl groups in the structure is significant. Hydroxyl (-OH) functional groups can greatly enhance solubility and reactivity, often playing a key role in biological activity and molecular interactions.
Potential Applications: Given its complex structure, this compound could have potential applications as a drug candidate in treating various neurological conditions. Research into its properties could unveil new pathways in drug development.
Research Directions: The combination of the benzodiazepine and pyrrolo structures presents a rich field for medicinal chemists. Studies focusing on structure-activity relationships (SAR) are crucial for optimizing efficacy and safety profiles of similar compounds.

In summary, 3-(4,6-dihydroxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)prop-2-enamide is not just a mouthful of a name, but a compound brimming with potential in the pharmaceutical landscape. Its unique structural aspects and biological implications make it an exciting subject for further investigation.

Synonyms

ANTHRAMYCIN

DTXSID60863456

3-(9,11-dihydroxy-8-methyl-5-oxo-5,10,11,11a-tetrahydro-1h-pyrrolo[2,1-c][1,4]benzodiazepin-2-yl)prop-2-enamide